Veraxa Biotech is trading 16.1% up today at $2.02, rebounding after last week’s weakness as risk appetite returns to the biotech sector.
- The move appears driven by a strong rally in the biotech space and broader risk-on sentiment rather than any new, company-specific catalyst.
- Recent price action reflects typical volatility for a small-cap biotech stock following a period of downward pressure.